Evaluation of ototoxicity in children treated for retinoblastoma: Preliminary results of a systematic audiological evaluation

Clinical and Translational Oncology

Volumn 13, Issue 5, 2011, Pages 348-352

  Pecora Liberman, Patricia Helena ^a   Schultz, Christiane ^a   Schmidt Goffi Gómez, María Valéria ^a   Antoneli, Célia B G ^b   Motoro Chojniak, Martha ^a   Novaes, Paulo Eduardo ^a  

^a A C CAMARGO CANCER CENTER   (Brazil)

^b UNIVERSITY OF SANTO AMARO   (Brazil)

Author keywords

Otoacoustic emissions Retinoblastoma Ototoxicity

Indexed keywords

CARBOPLATIN; CISPLATIN;

ARTICLE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; ENUCLEATION; EVOKED OTOACOUSTIC EMISSION; FEMALE; HEARING LOSS; HUMAN; MALE; OTOTOXICITY; PRESCHOOL CHILD; PURE TONE AUDIOMETRY; RETINOBLASTOMA; TYMPANOMETRY;

ACOUSTIC IMPEDANCE TESTS; ANTINEOPLASTIC AGENTS; AUDIOLOGY; AUDIOMETRY; CHILD; CISPLATIN; EAR DISEASES; FEMALE; HEARING LOSS; HUMANS; MALE; OTOACOUSTIC EMISSIONS, SPONTANEOUS; RETINOBLASTOMA; RISK;

EID: 79960691324     PISSN: 1699048X     EISSN: 16993055     Source Type: Journal    
DOI: 10.1007/s12094-011-0665-2     Document Type: Article

References (33)

1. Antoneli CB, Ribeiro KC, Steinhorst F et al (2006) Treatment of retinoblastoma patients with chemoreduction plus local therapy: experience of the AC Camargo Hospital, Brazil. J Pediatr Hematol Oncol 28:342-345 (Pubitemid 43970388)
2. Bertolini P, Lassalle M, Mercier G et al (2004) Platinum compound-related ototoxicity in children: long-term follow-up reveals continuous worsening of hearing loss. J Pediatr Hematol Oncol 26:649-655 (Pubitemid 39350398)
3. Skinner R (2004) Best practice in assessing ototoxicity in children with cancer. Eur J Cancer 40:2352-2354 (Pubitemid 39424946)
4. Liberman PHP, Schultz C, Pedalini MEB et al (2002) Monitorizaç ão auditiva em crianças portadoras de retinoblastoma: relato de dois casos. Acta Oncol Bras 22:250-254
5. MacDonald MR, Harrison RV, Wake M et al (1994) Ototoxicity of carboplatin: comparing animal and clinical models at the Hospital for Sick Children. J Otolaryngol 23:151-159 (Pubitemid 24238760)
6. Rybak LP (1999) Ototoxicity and antineoplastic drugs. Otolaryngol Head Neck Surg 7:239-243 (Pubitemid 32250608)
7. Zorowka PG, Schmitt HJ, Gutjahr P (1993) Evocated otoacoustic emission and pure tone threshold audiometry in patients receiving cisplatinum therapy. Int J Pediatr Otorhinolaryngol 25:73-80 (Pubitemid 23051642)
8. Kemp DT (1978) Stimulated acoustic emissions from within the human auditory system. J Acoust Soc Am 64:1386-1389
9. Allen C, Tiu C, Koike K et al (1998) Transientevoked otoacoustic emissions in children after cisplatin chemotherapy. Otolaryngol Head Neck Surg 118:584-588 (Pubitemid 28222198)
10. Hussain DM, Gorga MP, Neely ST et al (1998) Transient evoked otoacoustic emissions in patients with normal hearing and in patients with hearing loss. Ear Hear 19:434-449 (Pubitemid 29006048)
11. Hall JW III, Chandler D (1994) Tympanometry in clinical audiology. In: Katz J (ed.) Handbook of clinical audiology, 4th edn. William & Wilkins, Baltimore, pp 283-299
12. Hurley RM, Musiek FE (1994) Effectiveness of transient-evoked otoacoustic emissions (TEOAE) in predicting hearing level. J Am Acad Audiol 5: 195-203
13. Vohr BR, White KR, Maxon AB, Johnson MJ (1993) Factors affecting the interpretation of transient evoked otoacoustic emission results in neonatal hearing screening. Semin Hear 14:57-72 (Pubitemid 23093040)
14. Northern JL, Downs MP (1978) Clinical audiologic testing of children. In: Northern JL, Downs MP (eds) Hearing in children, 2nd edn. Williams & Wilkins, Baltimore, pp 113-147
15. Brock P, Bellman S, Yeomans EC et al (1991) Cisplatin ototoxicity in children: a pratical grading system. Med Pediatr Oncol 19:295-300
16. Friedman DL, Himelstein B, Shields CL et al (2000) Chemoreduction and local ophthalmic therapy for intraocular retinoblastoma. J Clin Oncol 18:12-17 (Pubitemid 30036331)
17. Smits C, Swen SJ, Theo Goverts S (2006) Assessment of hearing in very young children receiving carboplatin for retinoblastoma. Eur J Cancer 42:492-500 (Pubitemid 43227928)
18. Lambert MP, Shields C, Meadows AT (2008) A retrospective review of hearing in children with retinoblastoma treated with carboplatin-based chemotherapy. Pediatr Blood Cancer 50:223-226
19. Jehanne M, Mercier G, Doz F (2009) Monitoring of ototoxicity in young children receiving carboplatin for retinoblastoma. Pediatr Blood Cancer 53:1162
20. Namouni F, Doz F, Tanguy ML et al (1997) Highdose chemotherapy with carboplatin, etoposide and cyclophosphamide followed by a haematopoietic stem cell rescue in patients with high-risk retinoblastoma: a SFOP and SFGM study. Eur J Cancer 33:2368-2375 (Pubitemid 28129178)
21. Schultz C, Goffi-Gomez MV, Liberman PH, Carvalho AL (2009) Report on hearing loss in oncology. Braz J Otorhinolaryngol 75:634-641
22. Chang KW, Chinosornvatana N (2010) Practical grading system for evaluating cisplatin ototoxicity in children. J Clin Oncol 28:1788-1795
23. Bergeron C, Dubourg L, Chastagner P et al (2005) Long-term renal and hearing toxicity of carbopla tin in infants treated for localized and unresectable neuroblastoma: results of the SFOP NBL90 study. Pediatr Blood Cancer 45:32-36 (Pubitemid 40791743)
24. Li Y, Womer RB, Silber JH (2004) Predicting cisplatin ototoxicity in children: the influence of age and the cumulative dose. Eur J Cancer 40:2445-2451 (Pubitemid 39424959)
25. Langer T, Stohr W, Bielack S et al (2004) Late effects surveillance system for sarcoma patients. Pediatr Blood Cancer 42:373-379 (Pubitemid 38327633)
26. Liberman PHP (2005) Avaliação auditiva em pacientes tratados de câncer na infância. Dissertação de Mestrado-Fundação Antônio Prudente, São Paulo
27. Skinner MW (1978) The hearing of speech during language acquisition. Otolaryngol Clin North Am 11:631-650 (Pubitemid 9119110)
28. Paulino AC, Simon JH, Zhen W, Wen BC (2000) Long-term effects in children treated with radiotherapy for head and neck rhabdomyosarcoma. Int J Radiat Oncol Biol Phys 48: 1489-1495
29. Johannesen TB, Rasmussen K, Winther FO et al (2002) Late radiation effects on hearing, vestibular function, and taste in brain tumor patients. Int J Radiat Oncol Biol Phys 53:86-90 (Pubitemid 34465810)
30. Herrmann F, Dorr W, Muller R, Herrmann T (2006) A prospective study on radiation-induced changes in hearing function. Int J Radiat Oncol Biol Phys 65:1338-1344 (Pubitemid 44425222)
31. Pan CC, Eisbruch A, Lee JS et al (2005) Prospective study of inner ear radiation dose and hearing loss in head-and-neck cancer patients. Int J Radiat Oncol Biol Phys 61:1393-1402 (Pubitemid 40470420)
32. Barboni M, Geralde AT, Goffi-Gomez MVS et al (2006) Test-retest variability of the transient otoacoustic emissions in normal hearing subjects. Int Arch Otorhinolaryngol 10:119-124
33. Littman TA, Magruder A, Strother DR (1998) Monitoring and predicting ototoxic damage using distortion-product otoacoustic emissions: pediatric case study. J Am Acad Audiol 9:257-262